Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthma.

Autor: Busby J; Centre for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK., Matthews JG; 23 and Me, Sunnyvale, CA, USA., Chaudhuri R; NHS Greater Glasgow and Clyde Health Board, Gartnavel General Hospital and University of Glasgow, Glasgow, UK., Pavord ID; Oxford Respiratory NIHR BRC, Nuffield Dept of Medicine, The University of Oxford, Oxford, UK., Hardman TC; Niche Science & Technology Ltd, London, UK., Arron JR; Genentech Inc., South San Francisco, CA, USA., Bradding P; Dept of Respiratory Sciences, Institute for Lung Health and Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, UK., Brightling CE; Dept of Respiratory Sciences, Institute for Lung Health and Leicester NIHR Biomedical Research Centre, University of Leicester, Leicester, UK., Choy DF; Genentech Inc., South San Francisco, CA, USA., Cowan DC; NHS Greater Glasgow and Clyde, Stobhill Hospital, Glasgow, UK., Djukanovic R; School of Clinical and Experimental Sciences, University of Southampton, NIHR Southampton Biomedical Research Centre, Southampton, UK., Hanratty CE; Centre for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK., Harrison TW; Nottingham Respiratory NIHR Biomedical Research Centre, University of Nottingham, Nottingham, UK., Holweg CT; Genentech Inc., South San Francisco, CA, USA., Howarth PH; School of Clinical and Experimental Sciences, University of Southampton, NIHR Southampton Biomedical Research Centre, Southampton, UK., Fowler SJ; Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, and Manchester Academic Health Science Centre and NIHR Manchester Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Manchester, UK., Lordan JL; The Newcastle upon Tyne NHS Foundation Trust, Newcastle upon Tyne, UK., Mansur AH; University of Birmingham and Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Menzies-Gow A; Royal Brompton and Harefield NHS Foundation Trust, London, UK., Niven RM; Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, and Manchester Academic Health Science Centre and NIHR Manchester Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Manchester, UK., Robinson DS; University College Hospitals NHS Foundation Trust, London, UK., Walker SM; Asthma UK and British Lung Foundation Partnership, London, UK., Woodcock A; Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, and Manchester Academic Health Science Centre and NIHR Manchester Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Manchester, UK., Heaney LG; Centre for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK l.heaney@qub.ac.uk.

Publikováno v: The European respiratory journal [Eur Respir J] 2021 Sep 24; Vol. 59 (4). Date of Electronic Publication: 2021 Sep 24 (Print Publication: 2022).

Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials.

Autor: Hanania NA; Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, TX, USA. Electronic address: hanania@bcm.edu., Korenblat P; The Clinical Research Center LLC, St Louis, MI, USA., Chapman KR; Asthma and Airway Centre, University Health Network, University of Toronto, Toronto, ON, Canada; Division of Respiratory Medicine, Department of Medicine, University of Toronto, Toronto, ON, Canada., Bateman ED; Division of Pulmonology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Kopecky P; MediTrial s.r.o, Pulmonary Outpatient Clinic, Jindrichuv Hradec, Czech Republic., Paggiaro P; Department of Surgery, Medicine, Molecular Biology and Critical Care, University of Pisa, Pisa, Italy., Yokoyama A; Department of Hematology and Respiratory Medicine, Kochi Medical School, Kochi University, Kochi, Japan., Olsson J; Genentech (a member of the Roche Group), South San Francisco, CA, USA., Gray S; Genentech (a member of the Roche Group), South San Francisco, CA, USA., Holweg CT; Genentech (a member of the Roche Group), South San Francisco, CA, USA., Eisner M; Genentech (a member of the Roche Group), South San Francisco, CA, USA., Asare C; Genentech (a member of the Roche Group), South San Francisco, CA, USA., Fischer SK; Genentech (a member of the Roche Group), South San Francisco, CA, USA., Peng K; Genentech (a member of the Roche Group), South San Francisco, CA, USA., Putnam WS; Genentech (a member of the Roche Group), South San Francisco, CA, USA., Matthews JG; Genentech (a member of the Roche Group), South San Francisco, CA, USA.

Publikováno v: The Lancet. Respiratory medicine [Lancet Respir Med] 2016 Oct; Vol. 4 (10), pp. 781-796. Date of Electronic Publication: 2016 Sep 05.

Periostin levels and eosinophilic inflammation in poorly-controlled asthma.

Autor: Simpson JL; Department of Respiratory and Sleep Medicine, Hunter Medical Research Institute, Level 2, West Wing, Lot 1 Kookaburra Circuit, New Lambton Heights, NSW, 2305, Australia. jodie.simpson@newcastle.edu.au.; Priority Research Centre for Asthma and Respiratory Disease, The University of Newcastle, Newcastle, NSW, Australia. jodie.simpson@newcastle.edu.au., Yang IA; School of Medicine, The University of Queensland, Brisbane, QLD, Australia.; Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, QLD, Australia., Upham JW; School of Medicine, The University of Queensland, Brisbane, QLD, Australia.; Department of Respiratory Medicine, Princess Alexandra Hospital, Brisbane, QLD, Australia., Reynolds PN; Department of Thoracic Medicine, Royal Adelaide Hospital, Adelaide, SA, Australia.; Lung Research Laboratory, Hanson Institute, Adelaide, SA, Australia., Hodge S; Department of Thoracic Medicine, Royal Adelaide Hospital, Adelaide, SA, Australia.; Lung Research Laboratory, Hanson Institute, Adelaide, SA, Australia., James AL; Department of Pulmonary Physiology and Sleep Medicine, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.; School of Medicine and Pharmacology, The University of Western Australia, Crawley, WA, Australia., Jenkins C; Respiratory Trials, The George Institute for Global Health, Sydney, NSW, Australia.; Department of Thoracic Medicine, Concord General Hospital, Concord, NSW, Australia., Peters MJ; Australian School of Advanced Medicine, Macquarie University, Sydney, NSW, Australia.; Department of Thoracic Medicine, Concord General Hospital, Concord, NSW, Australia., Jia G; Genentech Inc, South San Francisco, CA, USA., Holweg CT; Genentech Inc, South San Francisco, CA, USA., Gibson PG; Department of Respiratory and Sleep Medicine, Hunter Medical Research Institute, Level 2, West Wing, Lot 1 Kookaburra Circuit, New Lambton Heights, NSW, 2305, Australia.; Priority Research Centre for Asthma and Respiratory Disease, The University of Newcastle, Newcastle, NSW, Australia.; Woolcock Institute of Medical Research, Glebe, NSW, Australia.

Publikováno v: BMC pulmonary medicine [BMC Pulm Med] 2016 Apr 30; Vol. 16 (1), pp. 67. Date of Electronic Publication: 2016 Apr 30.

The role of periostin in tissue remodeling across health and disease.

Autor: Conway SJ; Program in Developmental Biology and Neonatal Medicine, Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN, USA., Izuhara K, Kudo Y, Litvin J, Markwald R, Ouyang G, Arron JR, Holweg CT, Kudo A

Publikováno v: Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2014 Apr; Vol. 71 (7), pp. 1279-88. Date of Electronic Publication: 2013 Oct 22.